ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chaouat, A
Right arrow Articles by Kessler, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chaouat, A
Right arrow Articles by Kessler, R
Eur Respir J 1999; 13: 1091-1096
Copyright © ERS Journals Ltd 1999

Original Articles

Prognostic value of lung function and pulmonary haemodynamics in OSA patients treated with CPAP

A Chaouat, E Weitzenblum, J Krieger, E Sforza, H Hammad, M Oswald, and R Kessler

The aim of the present study was to determine survival rates of obstructive sleep apnoea patients treated with continuous positive airway pressure (CPAP) and to investigate the prognostic value of pretreatment lung function and pulmonary haemodynamics. Two hundred and ninety-six patients, exhibiting > or = 20 apnoeas plus hypopnoeas per hour of sleep, were included. Patients were treated with nasal CPAP and regularly followed up. The cumulative survival rates were 0.96 (95% confidence interval (CI): 0.94-0.99) at 3 yrs and 0.93 (95% CI: 0.91-0.97) at 5 yrs. Most patients died from cardiovascular disease. Apart from age, covariates associated with a lower survival were the presence of a heavy smoking history, a low vital capacity, a low forced expiratory volume in one second (FEV1) and a high mean pulmonary artery pressure. Only three covariates were included by forward stepwise selection in the multivariate analysis, smoking habit (>30 pack-yrs), age and FEV1. The observed survival rates of the group as a whole were similar to those of the general population matched in terms of age, sex and smoking habit, except for patients between 50 and 60 yrs old who had reduced survival. This difference disappeared when patients of the present study with an associated chronic obstructive pulmonary disease were excluded from the comparison. In conclusion, survival of obstructive sleep apnoea patients treated with nasal continuous positive airway pressure is near to that of the general population. The prognosis is worse in subgroups of patients with a history of heavy smoking and with an associated chronic obstructive pulmonary disease.


This article has been cited by other articles:


Home page
 Proc Am Thorac SocHome page
S. Krachman, O. A. Minai, and S. M. Scharf
Sleep Abnormalities and Treatment in Emphysema
Proceedings of the ATS, May 1, 2008; 5(4): 536 - 542.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
B. Mokhlesi and A. Tulaimat
Recent Advances in Obesity Hypoventilation Syndrome
Chest, October 1, 2007; 132(4): 1322 - 1336.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
F. Campos-Rodriguez, N. Pena-Grinan, N. Reyes-Nunez, I. De la Cruz-Moron, J. Perez-Ronchel, F. De la Vega-Gallardo, and A. Fernandez-Palacin
Mortality in Obstructive Sleep Apnea-Hypopnea Patients Treated With Positive Airway Pressure
Chest, August 1, 2005; 128(2): 624 - 633.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
S. Marti, G. Sampol, X. Munoz, F. Torres, A. Roca, P. Lloberes, T. Sagales, P. Quesada, and F. Morell
Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment
Eur. Respir. J., December 1, 2002; 20(6): 1511 - 1518.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the European Respiratory Society.